Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Globalization and Health
Published in: Globalization and Health 1/2014

Open Access 01-12-2014 | Research

Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013

Authors: Yibeltal Assefa, Achamyeleh Alebachew, Meskele Lera, Lut Lynen, Edwin Wouters, Wim Van Damme

Published in: Globalization and Health | Issue 1/2014

Login to get access

Abstract

Background

Antiretroviral treatment (ART) was provided to more than nine million people by the end of 2012. Although ART programs in resource-limited settings have expanded treatment, inadequate retention in care has been a challenge. Ethiopia has been scaling up ART and improving retention (defined as continuous engagement of patients in care) in care. We aimed to analyze the ART program in Ethiopia.

Methods

A mix of quantitative and qualitative methods was used. Routine ART program data was used to study ART scale up and patient retention in care. In-depth interviews and focus group discussions were conducted with program managers.

Results

The number of people receiving ART in Ethiopia increased from less than 9,000 in 2005 to more than 439, 000 in 2013. Initially, the public health approach, health system strengthening, community mobilization and provision of care and support services allowed scaling up of ART services. While ART was being scaled up, retention was recognized to be insufficient. To improve retention, a second wave of interventions, related to programmatic, structural, socio-cultural, and patient information systems, have been implemented. Retention rate increased from 77% in 2004/5 to 92% in 2012/13.

Conclusion

Ethiopia has been able to scale up ART and improve retention in care in spite of its limited resources. This has been possible due to interventions by the ART program, supported by health systems strengthening, community-based organizations and the communities themselves. ART programs in resource-limited settings need to put in place similar measures to scale up ART and retain patients in care.
Appendix
Available only for authorised users
Literature
1.
Chan KC, Wong KH, Lee SS: Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med. 2006, 7: 186-192. 10.1111/j.1468-1293.2006.00352.x.PubMedCrossRef
2.
Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, Balestre E, Sterne JA, May M, Egger M: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006, 367 (9513): 817-824.PubMedCrossRef
3.
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immune deficiency virus infection HIV Outpatient Study Investigators. N Engl J Med. 1998, 338: 853-860. 10.1056/NEJM199803263381301.PubMedCrossRef
4.
Mocroft A, Vella S, Benfield TL: Changing patterns of mortality across Europe in patients infected with HIV-1 EuroSIDA Study Group. Lancet. 1998, 352: 1725-1730. 10.1016/S0140-6736(98)03201-2.PubMedCrossRef
5.
UNAIDS: UNAIDS Report on the global AIDS epidemic | 2012. 2012, Geneva, Switzerland: UNAIDS
6.
UNAIDS: UNAIDS Report on the global AIDS epidemic | 2013. 2013, Geneva, Switzerland: UNAIDS
7.
WHO: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2013, Geneva, Switzerland: WHO
8.
Rosen S, Fox MP, Gill CJ: Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLoS Med. 2007, 4 (10): e298-10.1371/journal.pmed.0040298. doi:10.1371/journal.pmed.0040298.ePubMedPubMedCentralCrossRef
9.
WHO: Retention in HIV programmes: Defining the challenges and identifying solutions. 2012, Geneva, Switzerland: WHO
10.
Assefa Y, Van Damme W, Mariam DH, Kloos H: Toward Universal Access to HIV Counseling and Testing and Antiretroviral Treatment in Ethiopia: Looking Beyond HIV Testing and ART Initiation. AIDS Patient Care and STDs. 2010, 24 (8): doi:10.1089/apc.2009.0286
11.
Assefa Y, Jerene D, Luelseged S, Ooms G, Van Damme W: Rapid Scale-up of Antiretroviral Treatment in Ethiopia: Successes and System-wide Effects. PLoS Med. 2009, 6 (4): doi:10.1371/journal.pmed.1000056PubMedPubMedCentralCrossRef
12.
Assefa Y, Kloos H: The public health approach to ART service scale-up in Ethiopia: the first two years of free ART, 2005–2007. Ethiop Med J. 2008, 46 (4): 401-406.PubMed
13.
Federal Ministry of Health of Ethiopia: Guidelines for implementation of HIV/AIDS case management in Ethiopia. 2010, Addis Ababa, Ethiopia: FMOH
14.
Federal HIV/AIDS Prevention and Control Office: Monitoring and Evaluation Report, 2011/2012. 2013, Addis Ababa, Ethiopia: FHAPCO
15.
Federal HIV/AIDS Prevention and Control Office: Country Progress Report on HIV/AIDS Response, 2012. 2013, Addis Ababa, Ethiopia: FHAPCO
16.
Kloos H, Assefa Y, Adugna A, Mulatu MS, Mariam DH: Utilization of antiretroviral treatment in Ethiopia between February and December 2006: spatial, temporal, and demographic patterns. Int J Health Geograph. 2007, 6: 45 doi:10.1186/1476-072×-6-45CrossRef
17.
Assefa Y, Kiflie A, Tekle B, Mariam DH, Laga M, Van Damme W: Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia. J Health Serv Res Policy. 2012, 17 (1): 24-29. doi:10.1258/jhsrp.2011.010135PubMedCrossRef
18.
Federal Ministry of Health of Ethiopia: Health Center Construction Progress Report. 2013, Addis Ababa, Ethiopia: FMOH
19.
Pharmaceuticals Fund and Supply Agency: Progress report. 2013, Addis Ababa, Ethiopia: PFSA
20.
Ethiopian Health and Nutrition Research Institute: Progress report. 2013, Addis Ababa, Ethiopia: EHNRI
21.
Federal Ministry of Health of Ethiopia: Health and Health related Indicators. 2013, Addis Ababa, Ethiopia: FMOH
22.
Posse M, Baltussen R: Barriers to Access to Antiretroviral Treatment in Mozambique, as Perceived by Patients and Health Workers in Urban and Rural settings. AIDS Patients Care and STDs. 2009, 23 (10): 867-875. 10.1089/apc.2009.0050.CrossRef
23.
Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K: The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006, 368 (9534): 505-510. 10.1016/S0140-6736(06)69158-7.PubMedCrossRef
24.
WHO: Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the health sector. Progress Report, 2010. 2011, Geneva, Switzerland: WHO
25.
WHO: Task shifting: Rational redistribution of tasks among health workforce teams. Global recommendations and Guidelines. 2007, Geneva, Switzerland: WHO
26.
Assefa Y, Worku A, Wouters E, Koole O, Haile Mariam D, Van Damme W: Simplified Tools for Measuring Retention in Care in Antiretroviral Treatment Program in Ethiopia: Cohort and Current Retention in Care. PLoS One. 2012, 7 (6): e38555 doi:10.1371/journal.pone.0038555PubMedPubMedCentralCrossRef
27.
Assefa Y, Kiflie A, Tesfaye D, Mariam DH, Kloos H, Edwin W, Laga M, Van Damme W: Outcomes of antiretroviral treatment program in Ethiopia: Retention of patients in care is a major challenge and varies across health facilities. BMC Health Serv Res. 2011, 11: 81-10.1186/1472-6963-11-81. doi:10.1186/1472-6963-11-81PubMedPubMedCentralCrossRef
28.
Bedelu M, Ford N, Hilderbrand K, Reuter H: Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007, 196 (Suppl 3): S464-S468.PubMedCrossRef
29.
Massaquoi M, Zachariah R, Manzi M, Pasulani O, Misindi D, Mwagomba B, Bauernfeind A, Harries AD: Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Trans R Soc Trop Med Hyg. 2009, 103: 594-600. 10.1016/j.trstmh.2009.02.012.PubMedCrossRef
30.
Nash D, Korves C, Saito S: Characteristics of facilities and programs delivering HIV care and treatment services are associated with loss to follow-up rates in programs from 7 Sub-Saharan African countries. 2008, Montreal, Canada: 15th Conference on Retroviruses and Opportunistic Infections
31.
Chan AK, Mateyu G, Jahn A, Schouten E, Arora P, Mlotha W, Kambanji M, van Lettow M: Outcome Assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health. 2010, 15 (suppl. 1): 90-97.PubMedCrossRef
32.
Mutevedzi PC, Lessells RJ, Heller T, Bärnighausen T, Cooke GS, Newell ML: Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?. Bull World Health Organ. 2010, 88 (8): 593-600. 10.2471/BLT.09.069419.PubMedPubMedCentralCrossRef
33.
Mdege ND, Chindove S, Ali S: The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review. Health Policy Plan. 2012, doi:10.1093/heapol/czs058
34.
Callaghan M, Ford N, Schneider H: A systematic review of task- shifting for HIV treatment and care in Africa. Hum Resour Health. 2010, 8: 8 doi:10.1186/1478-4491-8-8PubMedPubMedCentralCrossRef
35.
Fairall L, Bachmann MO, Lombard C, Timmerman V, Uebel K, Zwarenstein M, Boulle A, Georgeu D, Colvin CJ, Lewin S, Faris G, Cornick R, Draper B, Tshabalala M, Kotze E, Van Vuuren C, Steyn D, Chapman R, Bateman E: Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. Lancet. 2012, 380 (9845): 889-898. 10. doi:10.1016/S0140-6736(12)60730-2. Epub 2012 Aug 15PubMedPubMedCentralCrossRef
36.
Boullé C, Kouanfack C, Laborde-Balen G, Carrieri MP, Dontsop M, Boyer S, Aghokeng AF, Spire B, Koulla-Shiro S, Delaporte E, Laurent C, Stratall ANRSESTHER Study Group: Task shifting HIV care in rural district hospitals in Cameroon: evidence of comparable antiretroviral treatment related outcomes between nurses and physicians in the Stratall ANRS/ESTHER trial. J Acquir Immune Defic Syndr. 2013, [Epub ahead of print]
37.
Shumbusho F, van Griensven J, Lowrance D, Turate I, Weaver MA, Price J, Binagwaho A: Task Shifting for Scale-up of HIV Care: Evaluation of Nurse-Centered Antiretroviral Treatment at Rural Health Centers in Rwanda. PLoS Med. 2009, 6 (10): e1000163 doi:10.1371/journal.pmed.1000163PubMedPubMedCentralCrossRef
38.
Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, Bekker LG, Wood R: Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One. 2010, 5 (11): e13801 doi:10.1371/journal.pone.0013801PubMedPubMedCentralCrossRef
39.
Rosen S, Fox MP: Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review. PLoS Med. 2011, 8 (7): doi:10.1371/journal.pmed.1001056PubMedPubMedCentralCrossRef
40.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, et al: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011, 365: 493-505. 10.1056/NEJMoa1105243.PubMedPubMedCentralCrossRef
41.
Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, Van Sighem A, De Wolf F, Bucher HC, Von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA, HIV-CAUSAL Collaboration: When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med. 2011, 154: 509-515.PubMedCrossRef
42.
Writing Committee for the CASCADE Collaboration: Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Arch Intern Med. 2011, 171: 1560-1569. 10.1001/archinternmed.2011.401.CrossRef
43.
Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, Chatham A, Raper JL, Saag MS, Mugavero MJ: The Therapeutic Implications of Timely Linkage and Early Retention in HIV Care. AIDS Patient Care STDS. 2009, 23 (1): 41-49. 10.1089/apc.2008.0132. doi:10.1089/apc.2008.0132PubMedPubMedCentralCrossRef
44.
WHO: Service delivery approaches to HIV testing and counseling (HTC): A strategic policy framework. 2012, Geneva, Switzerland: WHO
45.
WHO: The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. 2011, Geneva, Switzerland: WHO
46.
Deribe K, Hailekiros F, Biadgilign S, Amberbir A, Beyene BK: Defaulters from antiretroviral treatment in Jimma University Specialized Hospital Southwest Ethiopia. Trop Med Int Health. 2008, 13 (3): 328-333. 10.1111/j.1365-3156.2008.02006.x.PubMedCrossRef
47.
Geng E, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, Muyindike W, Bwana MB, Yiannoutsos CT, Petersen ML, Martin JN: Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010, 7 (4): 234-244. 10.1007/s11904-010-0061-5. doi:10.1007/s11904-010-0061-5PubMedPubMedCentralCrossRef
48.
Geng E, Bangsberg DR, Musinguzi NBA, Emenyonu N, Bwana MB, Yiannoutsos CT, Glidden DV, Deeks SG, Martin JN: Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach. JAIDS. 2010, 53: 405-411. doi:10.1097/QAI.0b013e3181b843f0PubMedPubMedCentral
49.
Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD: Transportation Costs Impede Sustained Adherence and Access to HAART in a Clinic Population in Southwestern Uganda: A Qualitative Study. AIDS Behav. 2010, 14 (4): 778-784. doi:10.1007/s10461-009-9533-2PubMedPubMedCentralCrossRef
50.
Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD: True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2009, 85: 501-568.
51.
Raguenaud ME, Isaakidis P, Vonthanak S: Good ART patient outcomes and survival achieved in a six-year HIV/AIDS program in Cambodia. 2009, Cape Town, South Africa: 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention
52.
Joshi K, Jhanwar S, Mathur A: Barriers in adherence of ART (antiretroviral treatment): a experience of ART Centre of Western Rajasthan, India. 2008, Mexico City, Mexico: 7th International AIDS Conference
53.
Maskew M, MacPhail P, Menezes C, Rubel D: Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007, 97 (9): 853-857.PubMed
54.
Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, Chersich MF, Venter WD: Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008, 47 (1): 101-107. 10.1097/QAI.0b013e31815b833a.PubMedCrossRef
55.
Emenyonu N, Thirumurthy H, Muyindike W: Cash transfers to cover clinic transportation costs improve adherence and retention in care in an HIV treatment program in rural Uganda. Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections. 2010, San Francisco: Abstract 831
56.
McGuire M, Munyenyembe T, Szumilin E, Heinzelmann A, Le Paih M, Bouithy N, Pujades-Rodríguez M: Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health. 2010, 15: 55-62.PubMedCrossRef
57.
Wanyama J, Castelnuovo B, Wandera B, Mwebaze P, Kambugu A, Bangsberg DR, Kamya MR: Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS. 2007, 21: 1486-1487. 10.1097/QAD.0b013e32823ecf7f.PubMedCrossRef
58.
Etienne M, Burrows L, Osotimehin B, Macharia T, Hossain B, Redfield RR, Amoroso A: Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Trop Med Int Health. 2010, 15: 76-81.PubMedCrossRef
59.
Wouters E, Van Damme W, van Rensburg D, Masquillier C, Meulemans H: Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review. BMC Health Serv Res. 2012, 12: 194-10.1186/1472-6963-12-194. doi:10.1186/1472-6963-12-194PubMedPubMedCentralCrossRef
60.
Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, Chalamilla G, Bangsberg DR: Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study. PLoS Med. 2009, 6 (1): e1000011-doi:10.1371/journal.pmed.1000011PubMedCentralCrossRef
61.
Rabkin M, Austin J, Nash D: High patient retention rates in a multinational HIV/AIDS treatment program: The Columbia University Mother-to-Child-Plus Experience. 2010, San Francisco, CA: 17th Conference on Retroviruses and Opportunistic Infections
62.
Wringe A, Roura M, Urassa M, Busza J, Athanas V, Zaba B: Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania. AIDS Care. 2009, 21: 632-637. 10.1080/09540120802385629.PubMedCrossRef
63.
Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, Yiannoutsos CT, Owiti M, Kimaiyo S, Braitstein P: Influence of gender on loss to follow-up in a large HIV treatment programme in Western Kenya. Bull World Health Organ. 2010, 88: 681-688. 10.2471/BLT.09.064329. doi:10.2471/BLT.09.064329PubMedPubMedCentralCrossRef
64.
Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, Spohr M, Balestre E, May M, Keiser O, Jahn A, Egger M, ART-LINC collaboration of International Epidemiological Databases to Evaluate AIDS: Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral theray programmes in resource-limited settings. Bull World Health Org. 2008, 86: 939-947. 10.2471/BLT.07.049908.PubMedPubMedCentralCrossRef
65.
Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, Coutinho A, Jaffar S: Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009, 9: 290-10.1186/1471-2458-9-290. doi:10.1186/1471-2458-9-290PubMedPubMedCentralCrossRef
Metadata
Title
Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013
Authors
Yibeltal Assefa
Achamyeleh Alebachew
Meskele Lera
Lut Lynen
Edwin Wouters
Wim Van Damme
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2014
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/1744-8603-10-43

Other articles of this Issue 1/2014

Globalization and Health 1/2014 Go to the issue

Research

Sexual violence and sub-Saharan migrants in Morocco: a community-based participatory assessment using respondent driven sampling

Research

Trade and investment liberalization and Asia’s noncommunicable disease epidemic: a synthesis of data and existing literature

Research

The global financial crisis and health equity: Early experiences from Canada

Research

The association between nutrition transition score and measures of obesity: results from a cross-sectional study among Latina/o immigrants in Baltimore

Research

Proposing a sequential comparative analysis for assessing multilateral health agency transformation and sustainable capacity: exploring the advantages of institutional theory

Debate

Global health impacts of policies: lessons from the UK